ED
45
2
ALLE
39
7
NOV
37
-2
COF
52
2
FDX
51
4
EMC
56
-7
NI
75
2
AIZ
42
2
R
66
-2
AMAT
57
-2
MDLZ
32
8
AMG
50
-2
AKAM
40
-2
COST
50
2
IRM
44
-5
CHD
24
-11
GS
62
-10
FMC
24
-5
KIM
51
-3
NWSA
75
2
ED
45
2
ALLE
39
7
NOV
37
-2
COF
52
2
FDX
51
4
EMC
56
-7
NI
75
2
AIZ
42
2
R
66
-2
AMAT
57
-2
MDLZ
32
8
AMG
50
-2
AKAM
40
-2
COST
50
2
IRM
44
-5
CHD
24
-11
GS
62
-10
FMC
24
-5
KIM
51
-3
NWSA
75
2
Financhill
Back

Lyra Therapeutics Stock Price Chart

Former Zillow exec targets $1.3T marke

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
39

LYRA
Lyra Therapeutics

Last Price:
$10.67
Seasonality Move:
12.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Notable investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
  • The current trend is moderately bearish and LYRA is experiencing selling pressure, which indicates risk of future bearish movement.

Lyra Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 11.87 Sell
20-day SMA: 13.08 Sell
50-day SMA: 8.25 Buy
200-day SMA: 9.92 Buy
8-day EMA: 12.16 Sell
20-day EMA: 12.24 Sell
50-day EMA: 10.07 Buy
200-day EMA: 22.87 Sell

Lyra Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.97 Buy
Relative Strength Index (14 RSI): 47.39 Sell
Chaikin Money Flow: -31350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.11 - 18.91) Sell
Bollinger Bands (100): (4.01 - 12.99) Buy

Lyra Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Lyra Therapeutics Stock

Is Lyra Therapeutics Stock a Buy?

  • Lyra Therapeutics share price is 10.45 while LYRA 8-day simple moving average is 11.87, which is a Sell signal.
  • The stock price of LYRA is 10.45 while Lyra Therapeutics 20-day SMA is 13.08, which makes it a Sell.
  • Lyra Therapeutics 50-day simple moving average is 8.25 while LYRA share price is 10.45, making it a Buy technically.
  • LYRA stock price is 10.45 and Lyra Therapeutics 200-day simple moving average is 9.92, creating a Buy signal.

LYRA Technical Analysis vs Fundamental Analysis

Sell
39
Lyra Therapeutics (LYRA) is a Sell

Is Lyra Therapeutics a Buy or a Sell?

  • Lyra Therapeutics stock is rated a Sell
    The current Lyra Therapeutics [LYRA] share price is $10.45. The Score for LYRA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.

Lyra Therapeutics Stock Info

Market Cap:
13.8M
Price in USD:
10.45
Share Volume:
47.8K

Lyra Therapeutics 52-Week Range

52-Week High:
37.50
52-Week Low:
3.81
Sell
39
Lyra Therapeutics (LYRA) is a Sell

Lyra Therapeutics Share Price Forecast

Is Lyra Therapeutics Stock a Buy?

  • Lyra Therapeutics share price is 10.45 while LYRA 8-day exponential moving average is 12.16, which is a Sell signal.
  • The stock price of LYRA is 10.45 while Lyra Therapeutics 20-day EMA is 12.24, which makes it a Sell.
  • Lyra Therapeutics 50-day exponential moving average is 10.07 while LYRA share price is 10.45, making it a Buy technically.
  • LYRA stock price is 10.45 and Lyra Therapeutics 200-day simple moving average is 22.87, creating a Sell signal.

Fundamental Analysis of Lyra Therapeutics

Is Lyra Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $5.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $42.75 per share, and an increase next year of $5.50 per share.

Technical Analysis of Lyra Therapeutics

Should I short Lyra Therapeutics stock?

* Lyra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.